Critical Insights From Abbott Laboratories Analyst Ratings: What You Need To Know
Portfolio Pulse from Benzinga Insights
Over the past three months, 5 analysts have evaluated Abbott Laboratories (NYSE:ABT), with ratings ranging from bullish to bearish. The average 12-month price target is $127.4, with a high of $140.00 and a low of $119.00. Recent analyst actions include both raises and lowers in ratings and price targets, reflecting changing market dynamics and company performance.
May 22, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Analysts have mixed views on Abbott Laboratories, with recent price targets averaging $127.4. The company's financial health shows strong net margins and ROA, but lower ROE compared to industry averages.
The mixed analyst ratings and slight decline in the average price target suggest a neutral short-term impact on ABT's stock price. The company's strong net margins and ROA are positive, but lower ROE and revenue growth compared to peers may offset these benefits.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100